Zur Rose Group has successfully completed the sale of its Swiss business to Migros
|
Zur Rose Group AG / Key word(s): Strategic Company Decision Frauenfeld, 4 May 2023 Press release Zur Rose Group has successfully completed the sale of its Swiss business to Migros The Zur Rose Group has successfully completed the sale of its Swiss business to the Migros subsidiary Medbase today. As the new owner of the Zur Rose Switzerland business, Medbase is taking over all the Zur Rose Group's operational units in Switzerland (excluding land and properties) with all employees. In view of the future strategic focus on the B2C core business, the Board of Directors proposes to today's Annual General Meeting to rename Zur Rose Group AG to DocMorris AG. With DocMorris – Germany's best-known health platform – the Group is strongly positioned in Germany and other European countries.
Investors and analyst contact Media contact Agenda
Zur Rose Group
End of Inside Information |
| Language: | English |
| Company: | Zur Rose Group AG |
| Walzmühlestrasse 60 | |
| 8500 Frauenfeld | |
| Switzerland | |
| Phone: | +41 52 724 08 14 |
| Internet: | www.zurrosegroup.com |
| ISIN: | CH0042615283 |
| Listed: | SIX Swiss Exchange |
| EQS News ID: | 1624557 |
| End of Announcement | EQS News Service |
|
|
1624557 04-May-2023 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.